U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Central Visual Field Defect

MedGen UID:
856667
•Concept ID:
C3897073
•
Finding

Definition

Reduced or abnormal sight in the central visual field. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVCentral Visual Field Defect

Professional guidelines

PubMed

Dysthyroid optic neuropathy: evaluation and management.
Dolman PJ
J Endocrinol Invest 2021 Mar;44(3):421-429. Epub 2020 Jul 29 doi: 10.1007/s40618-020-01361-y. PMID: 32729049
Inter-Eye Association of Visual Field Defects in Glaucoma and Its Clinical Utility.
Teng B, Li D, Choi EY, Shen LQ, Pasquale LR, Boland MV, Ramulu P, Wellik SR, De Moraes CG, Myers JS, Yousefi S, Nguyen T, Fan Y, Wang H, Bex PJ, Elze T, Wang M
Transl Vis Sci Technol 2020 Nov;9(12):22. Epub 2020 Nov 17 doi: 10.1167/tvst.9.12.22. PMID: 33244442Free PMC Article
The Diagnosis and Treatment of Age-Related Macular Degeneration.
Stahl A
Dtsch Arztebl Int 2020 Jul 20;117(29-30):513-520. doi: 10.3238/arztebl.2020.0513. PMID: 33087239Free PMC Article

Recent clinical studies

Etiology

Effects of glaucoma on detection and discrimination of image blur.
Bham HA, Denniss J
Ophthalmic Physiol Opt 2022 May;42(3):471-481. Epub 2022 Jan 24 doi: 10.1111/opo.12947. PMID: 35072288Free PMC Article
Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients.
Phu J, Kalloniatis M
Ophthalmology 2021 Oct;128(10):1405-1416. Epub 2021 Mar 17 doi: 10.1016/j.ophtha.2021.03.014. PMID: 33722636
Baseline Central Visual Field Defect as a Risk Factor For NTG Progression: A 5-Year Prospective Study.
Raman P, Suliman NB, Zahari M, Mohamad NF, Kook MS, Ramli N
J Glaucoma 2019 Nov;28(11):952-957. doi: 10.1097/IJG.0000000000001359. PMID: 31688446
Comparison of visual field tests in glaucoma patients with a central visual field defect.
Shin HY, Park HL, Park CK
Can J Ophthalmol 2019 Aug;54(4):489-494. Epub 2019 Jan 11 doi: 10.1016/j.jcjo.2018.11.006. PMID: 31358149
Relationship between ocular pulse amplitude and glaucomatous central visual field defect in normal-tension glaucoma.
Lee M, Cho EH, Lew HM, Ahn J
J Glaucoma 2012 Dec;21(9):596-600. doi: 10.1097/IJG.0b013e31824cfbf7. PMID: 22366705

Diagnosis

Effects of glaucoma on detection and discrimination of image blur.
Bham HA, Denniss J
Ophthalmic Physiol Opt 2022 May;42(3):471-481. Epub 2022 Jan 24 doi: 10.1111/opo.12947. PMID: 35072288Free PMC Article
Cortical oscillations can differentiate the gradient of the simulated central visual field defect.
Shi C, Liu S, Chen X, Tao L
Int J Psychophysiol 2021 Apr;162:40-48. Epub 2021 Feb 3 doi: 10.1016/j.ijpsycho.2021.01.021. PMID: 33548346
Baseline Central Visual Field Defect as a Risk Factor For NTG Progression: A 5-Year Prospective Study.
Raman P, Suliman NB, Zahari M, Mohamad NF, Kook MS, Ramli N
J Glaucoma 2019 Nov;28(11):952-957. doi: 10.1097/IJG.0000000000001359. PMID: 31688446
Comparison of visual field tests in glaucoma patients with a central visual field defect.
Shin HY, Park HL, Park CK
Can J Ophthalmol 2019 Aug;54(4):489-494. Epub 2019 Jan 11 doi: 10.1016/j.jcjo.2018.11.006. PMID: 31358149
Detection of central visual field defects in early glaucomatous eyes: Comparison of Humphrey and Octopus perimetry.
Roberti G, Manni G, Riva I, Holló G, Quaranta L, Agnifili L, Figus M, Giammaria S, Rastelli D, Oddone F
PLoS One 2017;12(10):e0186793. Epub 2017 Oct 27 doi: 10.1371/journal.pone.0186793. PMID: 29077730Free PMC Article

Therapy

Higher susceptibility to central crowding in glaucoma.
Blanckaert E, Rouland JF, Davost T, Warniez A, Boucart M
Clin Exp Optom 2024 Mar;107(2):227-233. Epub 2022 Oct 2 doi: 10.1080/08164622.2022.2124848. PMID: 36183782
Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients.
Phu J, Kalloniatis M
Ophthalmology 2021 Oct;128(10):1405-1416. Epub 2021 Mar 17 doi: 10.1016/j.ophtha.2021.03.014. PMID: 33722636
Detection of central visual field defects in early glaucomatous eyes: Comparison of Humphrey and Octopus perimetry.
Roberti G, Manni G, Riva I, Holló G, Quaranta L, Agnifili L, Figus M, Giammaria S, Rastelli D, Oddone F
PLoS One 2017;12(10):e0186793. Epub 2017 Oct 27 doi: 10.1371/journal.pone.0186793. PMID: 29077730Free PMC Article
Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M, Ohguro H, Takeuchi K, Miyagawa Y, Ito T, Metoki T
Ophthalmologica 2011;225(2):120-6. Epub 2010 Oct 16 doi: 10.1159/000320500. PMID: 20948238
Visual field changes in methotrexate therapy. Case report and review of the literature.
Sbeity ZH, Baydoun L, Schmidt S, Loeffler KU
J Med Liban 2006 Jul-Sep;54(3):164-7. PMID: 17190135

Prognosis

Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients.
Phu J, Kalloniatis M
Ophthalmology 2021 Oct;128(10):1405-1416. Epub 2021 Mar 17 doi: 10.1016/j.ophtha.2021.03.014. PMID: 33722636
Baseline Central Visual Field Defect as a Risk Factor For NTG Progression: A 5-Year Prospective Study.
Raman P, Suliman NB, Zahari M, Mohamad NF, Kook MS, Ramli N
J Glaucoma 2019 Nov;28(11):952-957. doi: 10.1097/IJG.0000000000001359. PMID: 31688446
Swedish Interactive Threshold Algorithm for central visual field defects unrelated to nerve fiber layer.
Hirasawa K, Shoji N
Graefes Arch Clin Exp Ophthalmol 2016 May;254(5):845-54. Epub 2015 Aug 18 doi: 10.1007/s00417-015-3132-x. PMID: 26279004
Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: an extended study.
Nakazawa M, Suzuki Y, Ito T, Metoki T, Kudo T, Ohguro H
Biomed Res Int 2013;2013:585729. Epub 2013 Nov 12 doi: 10.1155/2013/585729. PMID: 24319686Free PMC Article
Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M, Ohguro H, Takeuchi K, Miyagawa Y, Ito T, Metoki T
Ophthalmologica 2011;225(2):120-6. Epub 2010 Oct 16 doi: 10.1159/000320500. PMID: 20948238

Clinical prediction guides

Higher susceptibility to central crowding in glaucoma.
Blanckaert E, Rouland JF, Davost T, Warniez A, Boucart M
Clin Exp Optom 2024 Mar;107(2):227-233. Epub 2022 Oct 2 doi: 10.1080/08164622.2022.2124848. PMID: 36183782
Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients.
Phu J, Kalloniatis M
Ophthalmology 2021 Oct;128(10):1405-1416. Epub 2021 Mar 17 doi: 10.1016/j.ophtha.2021.03.014. PMID: 33722636
Cortical oscillations can differentiate the gradient of the simulated central visual field defect.
Shi C, Liu S, Chen X, Tao L
Int J Psychophysiol 2021 Apr;162:40-48. Epub 2021 Feb 3 doi: 10.1016/j.ijpsycho.2021.01.021. PMID: 33548346
Swedish Interactive Threshold Algorithm for central visual field defects unrelated to nerve fiber layer.
Hirasawa K, Shoji N
Graefes Arch Clin Exp Ophthalmol 2016 May;254(5):845-54. Epub 2015 Aug 18 doi: 10.1007/s00417-015-3132-x. PMID: 26279004
Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M, Ohguro H, Takeuchi K, Miyagawa Y, Ito T, Metoki T
Ophthalmologica 2011;225(2):120-6. Epub 2010 Oct 16 doi: 10.1159/000320500. PMID: 20948238

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...